Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Denali Therapeutics Inc. | Chief Medical Officer | Common Stock | 119K | $2.97M | $24.96 | Aug 21, 2024 | Direct |
Denali Therapeutics Inc. | Chief Medical Officer | Common Stock | 25K | $624K | $24.96 | Aug 20, 2024 | Indirect |
Beam Therapeutics Inc. | Director | Stock Option (Right to Buy) | 23.1K | $564K | $24.40 | Jun 5, 2024 | Direct |
Denali Therapeutics Inc. | Chief Medical Officer | Stock Option (right to buy) | 161K | Jan 3, 2024 | Direct | ||
NGM BIOPHARMACEUTICALS INC | Director | Stock Option (Right to Buy) | 0 | Apr 5, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
DNLI | Denali Therapeutics Inc. | Aug 20, 2024 | 3 | -$550K | 4 | Aug 22, 2024 | Chief Medical Officer |
DNLI | Denali Therapeutics Inc. | Aug 13, 2024 | 1 | -$53.5K | 4 | Aug 15, 2024 | Chief Medical Officer |
BEAM | Beam Therapeutics Inc. | Jun 5, 2024 | 1 | $0 | 4 | Jun 7, 2024 | Director |
NGM | NGM BIOPHARMACEUTICALS INC | Apr 5, 2024 | 4 | $0 | 4 | Apr 8, 2024 | Director |
DNLI | Denali Therapeutics Inc. | Feb 13, 2024 | 2 | -$73.1K | 4 | Feb 15, 2024 | Chief Medical Officer |
DNLI | Denali Therapeutics Inc. | Jan 10, 2024 | 1 | -$88.8K | 4 | Jan 12, 2024 | Chief Medical Officer |
DNLI | Denali Therapeutics Inc. | Jan 5, 2024 | 1 | -$194K | 4 | Jan 9, 2024 | Chief Medical Officer |
DNLI | Denali Therapeutics Inc. | Jan 3, 2024 | 2 | $0 | 4 | Jan 5, 2024 | Chief Medical Officer |
DNLI | Denali Therapeutics Inc. | Aug 23, 2023 | 1 | -$58.6K | 4 | Aug 25, 2023 | Chief Medical Officer |
DNLI | Denali Therapeutics Inc. | Aug 21, 2023 | 1 | -$56K | 4 | Aug 23, 2023 | Chief Medical Officer |
DNLI | Denali Therapeutics Inc. | Aug 14, 2023 | 1 | -$65.9K | 4 | Aug 16, 2023 | Chief Medical Officer |
DNLI | Denali Therapeutics Inc. | Aug 10, 2023 | 1 | -$69K | 4 | Aug 14, 2023 | Chief Medical Officer |
BEAM | Beam Therapeutics Inc. | Jun 6, 2023 | 1 | $0 | 4 | Jun 8, 2023 | Director |
NGM | NGM BIOPHARMACEUTICALS INC | May 10, 2023 | 1 | $0 | 4 | May 12, 2023 | Director |
DNLI | Denali Therapeutics Inc. | Feb 15, 2023 | 1 | -$43.4K | 4 | Feb 17, 2023 | Chief Medical Officer |
DNLI | Denali Therapeutics Inc. | Feb 10, 2023 | 2 | -$101K | 4 | Feb 14, 2023 | Chief Medical Officer |
DNLI | Denali Therapeutics Inc. | Feb 8, 2023 | 1 | -$47K | 4 | Feb 10, 2023 | Chief Medical Officer |
DNLI | Denali Therapeutics Inc. | Jan 9, 2023 | 1 | -$41.6K | 4 | Jan 10, 2023 | Chief Medical Officer |
DNLI | Denali Therapeutics Inc. | Jan 5, 2023 | 2 | -$117K | 4 | Jan 9, 2023 | Chief Medical Officer |
DNLI | Denali Therapeutics Inc. | Jan 3, 2023 | 3 | -$83.6K | 4 | Jan 5, 2023 | Chief Medical Officer |
BEAM | Beam Therapeutics Inc. | Sep 1, 2022 | 1 | $0 | 4 | Sep 2, 2022 | Director |
DNLI | Denali Therapeutics Inc. | Aug 23, 2022 | 1 | -$77.5K | 4 | Aug 25, 2022 | Chief Medical Officer |
DNLI | Denali Therapeutics Inc. | Aug 19, 2022 | 1 | -$85.6K | 4 | Aug 23, 2022 | Chief Medical Officer |
DNLI | Denali Therapeutics Inc. | Aug 9, 2022 | 1 | $0 | 4 | Aug 11, 2022 | Chief Medical Officer |
NGM | NGM BIOPHARMACEUTICALS INC | May 18, 2022 | 1 | $0 | 4 | May 20, 2022 | Director |
DNLI | Denali Therapeutics Inc. | Feb 11, 2022 | 1 | -$101K | 4 | Feb 15, 2022 | Chief Medical Officer |
DNLI | Denali Therapeutics Inc. | Feb 9, 2022 | 1 | -$52.8K | 4 | Feb 11, 2022 | Chief Medical Officer |
DNLI | Denali Therapeutics Inc. | Jan 5, 2022 | 1 | -$127K | 4 | Jan 7, 2022 | Chief Medical Officer |
DNLI | Denali Therapeutics Inc. | Jan 3, 2022 | 2 | $0 | 4 | Jan 5, 2022 | Chief Medical Officer |
DNLI | Denali Therapeutics Inc. | Dec 6, 2021 | 1 | -$62.8K | 4 | Dec 8, 2021 | Chief Medical Officer |
DNLI | Denali Therapeutics Inc. | Aug 23, 2021 | 1 | -$300K | 4 | Aug 25, 2021 | Chief Medical Officer |
DNLI | Denali Therapeutics Inc. | Aug 19, 2021 | 2 | -$126K | 4 | Aug 23, 2021 | Chief Medical Officer |
BEAM | Beam Therapeutics Inc. | Jun 10, 2021 | 1 | $0 | 4 | Jun 14, 2021 | Director |
NGM | NGM BIOPHARMACEUTICALS INC | Jun 8, 2021 | 1 | $0 | 4 | Jun 10, 2021 | Director |